Home
 
Choose Your City
Change City

Pink Pill Victory! FDA approves 'female Viagra' and it's out in October

Critics: Flibanserin (a/k/a Viagra for women) little more than a placebo.

FDA has greenlighted the pink pill.

Reuters


The U.S. Food and Drug Administration has approved the drug Flibanserin -- the female version of Viagra that critics say is little more than a placebo.

The brand name of the Sprout Pharmaceuticals drug, which is available in October, is Addyi.

RELATED: Even critics called marketing campaign brilliant.

While called "female Viagra" by the media, the drug has no relation to the blue Pfizer erectile dysfunction drug for men, which has been a huge money maker for the company: $1.6 billion last year.

The drug works on the female libido, Sprout says.

The new drug is meant to aid women with Hypoactive Sexual Desire Disorderand works by increasing dopamine and norepinephrine in the brain while decreasing serotonin, reports the science site HypothesisMag.com.

RELATED:Will theFierarevolutionize women's sex lives?

Sprout has reported that, in clinical trials, 37% of women experienced an increase in sexual desire.

Critics, like PharmedOuthave railed sgainst the over-dependence on pills. But another group, Even the Score , has noted that researchers haven't done anything like they've done to help men have better sex and backed Sprout's new medication,

"Women's sexuality is very complicated. It's not a matter of just taking that pill, by the way, and then all of a sudden the lights go on," Judy Kuriansky, a clinical psychologist and certified sex therapist told CNN.

"You have to feel good about your body. You have to feel good about yourself. You have to feel the guy really loves you...It's complex. It's not the same as a man taking a pill."

John A. Oswald is editor-at-large at Metro and can be found on Twitter@nyc_oz.
LikeMetro New York,Metro US,Metro BostonandMetro Phillyon Facebook and join the conversation.

 

Consider AlsoFurther Articles